Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Rx-360 Consortium Aims to Curb Pharmaceutical Supply Chain Threats

This article was originally published in The Gold Sheet

Executive Summary

Rx-360 Consortium answers the call to develop a global solution to the pharmaceutical supply chain crisis exemplified by last year's heparin adulteration. The consortium, which brings a holistic perspective and a bias for action, will meet June 5 in Washington to chart its course. Its three-year plan calls for adopting and when necessary setting standards, identifying and sharing potential adulteration threats such as the current shortage of acetonitrile, sharing information from audits of suppliers and developing new technologies with the help of research universities. The group envisions a flexible audit-sharing system that could include second- and third-party audits that might be built on an IT platform originally developed to share audits of working conditions.

You may also be interested in...

Coronavirus Supply Chain Threats Demand Coordinated Industry Response

Just as they did during the heparin crisis a decade ago, pharmaceutical companies must coordinate on coronavirus, Rx-360 CEO says.

Traceable Supply Chain Is “End Game” To Stop Counterfeits, FDA Risk Advisor Says

FDA’s risk communications cannot outpace counterfeiters, advisory committee member warns, citing the need for more rigorous supply chain controls; meanwhile, agency’s counterfeit drug alerts aimed at physicians draw industry praise.

Drug Firms Can Share GMP Data From Supplier Audits, FTC Says

Rx-360 International Pharmaceutical Supply Chain Consortium plans to share information about the quality and safety of ingredients purchased from common suppliers.

Related Content




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts